MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Design and discovery of 1,2,4 triazole derivatives as adenosine A2A receptor antagonist against parkinson’s disease

    A. Verma, V. Kumar, U. Singh (Allahabad, India)

    Objective: In the present study, we intended to develop novel 1,2,4 triazole as potent A(2A)AR antagonists against parkinson’s disease. Background: Parkinson’s disease (PD) is a…
  • 2017 International Congress

    Alternative Apomorphine Challenge Test

    J.C. Martinez Castrillo, A. Alonso Canovas, C. Estevez Fraga, G. Sanchez Diez, I. Avilés Olmos, J. Lopez Sendon, P. Garcia Ruiz, L. Vela Desojo (Madrid, Spain)

    Objective: To propose a new apomorphine challenge test Background: In the standard apomorphine challenge test, the appropriate dose of apomorphine is established by incremental dosing…
  • 2017 International Congress

    Neuroprotection and Alleviation of Parkinsonian Phenotypes by Ayurvedic Herbs

    S. Singh, J. Prakash, S. Yadav (Varanasi, India)

    Objective: Our laboratory has focused on the herbal treatment of Parkinson’s disease especially by the above two common herbs Withania somnifera (Ws) and Mucuna pruriens…
  • 2017 International Congress

    Effects of non-invasive electrical and magnetic stimulation to improve motor and cognitive function in Parkinson’s disease: a meta-analytical review

    A. Goodwill, J. Lum, A. Hendy, M. Muthalib, L. Johnson, N. Albein-Urios, W.-P. Teo (Burwood, Australia)

    Objective: This meta-analytical review aims to compare 1) the effects of non-invasive repetitive transcranial magnetic (rTMS) and transcranial electrical stimulation (tES); and 2) identify optimal…
  • 2017 International Congress

    Istradefylline improves motor symptoms in Parkinson’s disease: A meta-analysis

    W. Sako, N. Murakami, K. Motohama, Y. Izumi, R. Kaji (Tokushima, Japan)

    Objective: The aim of this meta-analysis was to provide strong evidence for the main and side effects of istradefylline on patients with Parkinson’s disease. Background:…
  • 2017 International Congress

    Clinical features and response to botulinum toxin in primary and secondary hemifacial spasm

    S. Pandey, S. Jain (New Delhi, India)

    Objective: To study demographic and clinical features of  primary and secondary hemifacial spasm and assess their response to botulinum toxin therapy. Background: Hemifacial spasm (HFS)…
  • 2017 International Congress

    Dopamine replacement medication improves acquisition, retention, and transfer of skilled upper extremity movement in people with Parkinson Disease.

    S. Paul, C. Walter, G. Olivier, L. Dibble, S. Schaefer (Salt Lake City, UT, USA)

    Objective: To determine whether i) dopamine replacement medication affects learning of an upper limb (UL) feeding task in people with Parkinson disease (PD), and ii) training…
  • 2017 International Congress

    Evaluation of the short-term and long-term effects of an intensive multidisciplinary collective rehabilitation program over 5 weeks in Parkinson’s patients followed in Lyon

    T. DANAILA, C. LAURENCIN, P. ROCHE, S. THOBOIS, M. CHEMINON, J. LUAUTE (BRON, France)

    Objective: We studied the value of collective (8 patients per group) intensive multidisciplinary collective rehabilitation in the short and long term. Background: Numerous studies have proved…
  • 2017 International Congress

    Antisense oligonucleotides containing amido-bridged nucleic acid downregulate SNCA expression and improve motor function in Parkinson’s disease mouse models.

    T. Uehara, C.-J. Choong, H. Hayakawa, Y. Kasahara, T. Nagata, T. Yokota, K. Baba, M. Nakamori, S. Obika, H. Mochizuki (Suita-Shi, Osaka, Japan)

    Objective: In this study, we used gapmer-type antisense oligonucleotides (ASOs) containing amido-bridged nucleic acid (AmNA). ASO, short single-stranded stretches of DNA or RNA with complementary…
  • 2017 International Congress

    Parkinson’s Disease Medications Availability in Each Philippine Region

    S. Villaraza, C. Go (Manila, Philippines)

    Objective: This study aimed to enumerate the different Parkinson’s disease medications in the Philippines and describe the distribution and availability among the 17 regions of…
  • « Previous Page
  • 1
  • …
  • 1648
  • 1649
  • 1650
  • 1651
  • 1652
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley